Metabolic syndrome (MetS) is a multifaceted disorder that impacts approximately 20–25% of the global population. This syndrome encompasses a range of conditions, including obesity, type 2 diabetes ...
A Prescription Drug User Fee Act target date of December 20, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) ...
March 20, 2026 PDUFA goal date for sNDA for setmelanotide in acquired hypothalamic obesity -- BOSTON, March 01, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global ...
Before GLP-1 agonists became the blockbuster obesity drugs many people know and use today, Rhythm Pharmaceuticals was researching molecules that take a similar approach but for a different target. The ...
Researchers discover a gut-brain-heart axis where the bacterial metabolite IAA regulates hypocretin neurons to control heart stiffness and blood pressure.
Hosted on MSN
Central Hypothyroidism Causes and Treatment
Central hypothyroidism is a rare disorder that occurs when an otherwise healthy thyroid doesn't produce enough hormone due to problems that originate in the pituitary gland, the hypothalamus, or both.
Researchers identify a neural circuit in the lateral hypothalamus that suppresses itch during acute stress, offering new insights into chronic itch management.
Rhythm Pharmaceuticals Inc. is set to report fourth-quarter results Thursday before the market opens, delivering a crucial financial snapshot just weeks before a regulatory decision that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results